{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T06:21:18Z","timestamp":1792736478193,"version":"4.5.0"},"reference-count":58,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2012,6,19]],"date-time":"2012-06-19T00:00:00Z","timestamp":1340064000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0039113","type":"journal-article","created":{"date-parts":[[2012,6,19]],"date-time":"2012-06-19T16:55:17Z","timestamp":1340124917000},"page":"e39113","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":140,"title":["Inhibition of Apoptosis Blocks Human Motor Neuron Cell Death in a Stem Cell Model of Spinal Muscular Atrophy"],"prefix":"10.1371","volume":"7","author":[{"given":"Dhruv","family":"Sareen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison D.","family":"Ebert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brittany M.","family":"Heins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jered V.","family":"McGivern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loren","family":"Ornelas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clive N.","family":"Svendsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2012,6,19]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/ng0797-265","article-title":"Correlation between severity and SMN protein level in spinal muscular atrophy.","volume":"16","author":"S Lefebvre","year":"1997","journal-title":"Nat Genet"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/BF00212028","article-title":"Linkage mapping of the spinal muscular atrophy gene.","volume":"93","author":"AH Burghes","year":"1994","journal-title":"Hum Genet"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1093\/hmg\/7.10.1531","article-title":"The role of the SMN gene in proximal spinal muscular atrophy.","volume":"7","author":"S Lefebvre","year":"1998","journal-title":"Hum Mol Genet"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"I37","DOI":"10.1007\/s004150050555","article-title":"The role of SMN in spinal muscular atrophy.","volume":"247","author":"S Jablonka","year":"2000","journal-title":"J Neurol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"e921","DOI":"10.1371\/journal.pone.0000921","article-title":"Ribonucleoprotein assembly defects correlate with spinal muscular atrophy severity and preferentially affect a subset of spliceosomal snRNPs.","volume":"2","author":"F Gabanella","year":"2007","journal-title":"PLoS One"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nrn2670","article-title":"Spinal muscular atrophy: why do low levels of survival motor neuron protein make motor neurons sick?","volume":"10","author":"AH Burghes","year":"2009","journal-title":"Nat Rev Neurosci"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.ajhg.2009.08.002","article-title":"A positive modifier of spinal muscular atrophy in the SMN2 gene.","volume":"85","author":"TW Prior","year":"2009","journal-title":"Am J Hum Genet"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/hmg\/9.3.333","article-title":"The human centromeric survival motor neuron gene (SMN2) rescues embryonic lethality in Smn(\u2212\/\u2212) mice and results in a mouse with spinal muscular atrophy.","volume":"9","author":"UR Monani","year":"2000","journal-title":"Hum Mol Genet"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1038\/sj.gt.3301550","article-title":"An in vivo reporter system for measuring increased inclusion of exon 7 in SMN2 mRNA: potential therapy of SMA.","volume":"8","author":"ML Zhang","year":"2001","journal-title":"Gene Ther"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1093\/hmg\/ddi131","article-title":"A non-sequence-specific requirement for SMN protein activity: the role of aminoglycosides in inducing elevated SMN protein levels.","volume":"14","author":"EC Wolstencroft","year":"2005","journal-title":"Hum Mol Genet"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/nn.2565","article-title":"Therapy development in spinal muscular atrophy.","volume":"13","author":"M Sendtner","year":"2010","journal-title":"Nat Neurosci"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1177\/0883073807305665","article-title":"Perspectives on clinical trials in spinal muscular atrophy.","volume":"22","author":"KJ Swoboda","year":"2007","journal-title":"J Child Neurol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0092-8674(95)90461-1","article-title":"The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy.","volume":"80","author":"N Roy","year":"1995","journal-title":"Cell"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/hmg\/6.2.229","article-title":"A multicopy transcription-repair gene, BTF2p44, maps to the SMA region and demonstrates SMA associated deletions.","volume":"6","author":"TA Carter","year":"1997","journal-title":"Hum Mol Genet"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.braindev.2008.08.012","article-title":"Combination of SMN2 copy number and NAIP deletion predicts disease severity in spinal muscular atrophy.","volume":"31","author":"MS Watihayati","year":"2009","journal-title":"Brain Dev"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/37144","article-title":"Synergistic anti-apoptotic activity between Bcl-2 and SMN implicated in spinal muscular atrophy.","volume":"390","author":"H Iwahashi","year":"1997","journal-title":"Nature"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1136\/jmg.37.7.536","article-title":"Does the survival motor neuron protein (SMN) interact with Bcl-2?","volume":"37","author":"DD Coovert","year":"2000","journal-title":"J Med Genet"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1093\/hmg\/ddi078","article-title":"SMNDelta7, the major product of the centromeric survival motor neuron (SMN2) gene, extends survival in mice with spinal muscular atrophy and associates with full-length SMN.","volume":"14","author":"TT Le","year":"2005","journal-title":"Hum Mol Genet"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"13312","DOI":"10.1073\/pnas.230364197","article-title":"Survival motor neuron protein modulates neuron-specific apoptosis.","volume":"97","author":"DA Kerr","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.nbd.2008.05.014","article-title":"Restoring Bcl-x(L) levels benefits a mouse model of spinal muscular atrophy.","volume":"31","author":"LK Tsai","year":"2008","journal-title":"Neurobiol Dis"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.ymthe.2006.02.008","article-title":"Abolishing Bax-dependent apoptosis shows beneficial effects on spinal muscular atrophy model mice.","volume":"13","author":"MS Tsai","year":"2006","journal-title":"Mol Ther"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/BF03033366","article-title":"Survival motor neuron protein regulates apoptosis in an in vitro model of spinal muscular atrophy.","volume":"13","author":"GC Parker","year":"2008","journal-title":"Neurotox Res"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s10048-009-0200-6","article-title":"Reduced levels of survival motor neuron protein leads to aberrant motoneuron growth in a Xenopus model of muscular atrophy.","volume":"11","author":"Q Ymlahi-Ouazzani","year":"2010","journal-title":"Neurogenetics"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1083\/jcb.200208079","article-title":"A transgene carrying an A2G missense mutation in the SMN gene modulates phenotypic severity in mice with severe (type I) spinal muscular atrophy.","volume":"160","author":"UR Monani","year":"2003","journal-title":"J Cell Biol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/71709","article-title":"A mouse model for spinal muscular atrophy.","volume":"24","author":"HM Hsieh-Li","year":"2000","journal-title":"Nat Genet"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.nbd.2010.01.006","article-title":"Neuromuscular defects and breathing disorders in a new mouse model of spinal muscular atrophy.","volume":"38","author":"M Michaud","year":"2010","journal-title":"Neurobiol Dis"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","article-title":"Induction of pluripotent stem cells from adult human fibroblasts by defined factors.","volume":"131","author":"K Takahashi","year":"2007","journal-title":"Cell"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1126\/science.1151526","article-title":"Induced pluripotent stem cell lines derived from human somatic cells.","volume":"318","author":"J Yu","year":"2007","journal-title":"Science"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nature06534","article-title":"Reprogramming of human somatic cells to pluripotency with defined factors.","volume":"451","author":"IH Park","year":"2008","journal-title":"Nature"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S1474-4422(11)70022-9","article-title":"Induced pluripotent stem cells: a new revolution for clinical neurology?","volume":"10","author":"VB Mattis","year":"2011","journal-title":"Lancet Neurol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/nature07677","article-title":"Induced pluripotent stem cells from a spinal muscular atrophy patient.","volume":"457","author":"AD Ebert","year":"2009","journal-title":"Nature"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.stem.2011.03.002","article-title":"A call for standardized naming and reporting of human ESC and iPSC lines.","volume":"8","author":"MX Luong","year":"2011","journal-title":"Cell Stem Cell"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1126\/science.1172482","article-title":"Human induced pluripotent stem cells free of vector and transgene sequences.","volume":"324","author":"J Yu","year":"2009","journal-title":"Science"},{"key":"ref34","article-title":"Induced pluripotent stem cells from patients with Huntington\u2019s Disease show CAG repeat-associated phenotypes. Cell Stem Cell.","author":"Consortium The Huntington\u2019s Disease iPS","year":"2012"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1634\/stemcells.2007-0620","article-title":"Directed differentiation of ventral spinal progenitors and motor neurons from human embryonic stem cells by small molecules.","volume":"26","author":"XJ Li","year":"2008","journal-title":"Stem Cells"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"3708","DOI":"10.1167\/iovs.06-0119","article-title":"Mitochondria as the primary target of resveratrol-induced apoptosis in human retinoblastoma cells.","volume":"47","author":"D Sareen","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/cdd.2009.130","article-title":"Caspase-mediated inhibition of sphingomyelin synthesis is involved in FasL-triggered cell death.","volume":"17","author":"E Lafont","year":"2010","journal-title":"Cell Death Differ"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.2337\/db05-1430","article-title":"Low concentration of interleukin-1beta induces FLICE-inhibitory protein-mediated beta-cell proliferation in human pancreatic islets.","volume":"55","author":"K Maedler","year":"2006","journal-title":"Diabetes"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1002\/stem.31","article-title":"Directed differentiation of human-induced pluripotent stem cells generates active motor neurons.","volume":"27","author":"S Karumbayaram","year":"2009","journal-title":"Stem Cells"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.braindev.2010.06.009","article-title":"New insights into the pathogenesis of spinal muscular atrophy.","volume":"33","author":"Y Ito","year":"2011","journal-title":"Brain Dev"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nbt.1783","article-title":"A functionally characterized test set of human induced pluripotent stem cells.","volume":"29","author":"GL Boulting","year":"2011","journal-title":"Nat Biotechnol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1002\/stem.749","article-title":"Phenotypic Rescue of Induced Pluripotent Stem Cell-Derived Motoneurons of a Spinal Muscular Atrophy Patient.","volume":"29","author":"T Chang","year":"2011","journal-title":"Stem Cells"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"9920","DOI":"10.1073\/pnas.94.18.9920","article-title":"Inactivation of the survival motor neuron gene, a candidate gene for human spinal muscular atrophy, leads to massive cell death in early mouse embryos.","volume":"94","author":"B Schrank","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1101\/gad.12.11.1551","article-title":"Proteases to die for.","volume":"12","author":"V Cryns","year":"1998","journal-title":"Genes Dev"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2007.09.025","article-title":"Knockdown of SMN by RNA interference induces apoptosis in differentiated P19 neural stem cells.","volume":"1183","author":"B Trulzsch","year":"2007","journal-title":"Brain Res"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1126\/science.2011743","article-title":"Control of embryonic motoneuron survival in vivo by ciliary neurotrophic factor.","volume":"251","author":"RW Oppenheim","year":"1991","journal-title":"Science"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1083\/jcb.147.5.1049","article-title":"Programmed cell death of embryonic motoneurons triggered through the Fas death receptor.","volume":"147","author":"C Raoul","year":"1999","journal-title":"J Cell Biol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1083\/jcb.200908164","article-title":"Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond.","volume":"187","author":"H Ilieva","year":"2009","journal-title":"J Cell Biol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1126\/science.1086071","article-title":"Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice.","volume":"302","author":"AM Clement","year":"2003","journal-title":"Science"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/1471-2202-6-68","article-title":"Astrocyte reactivity to Fas activation is attenuated in TIMP-1 deficient mice, an in vitro study.","volume":"6","author":"C Ogier","year":"2005","journal-title":"BMC Neurosci"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1471-4159.2010.07124.x","article-title":"Fas ligation and tumor necrosis factor alpha activation of murine astrocytes promote heat shock factor-1 activation and heat shock protein expression leading to chemokine induction and cell survival.","volume":"116","author":"K Choi","year":"2011","journal-title":"J Neurochem"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.2174\/138161210793176527","article-title":"Monoamine oxidase inhibitors as neuroprotective agents in age-dependent neurodegenerative disorders.","volume":"16","author":"M Naoi","year":"2010","journal-title":"Curr Pharm Des"},{"key":"ref53","first-page":"911","article-title":"Dexpramipexole, the R(+) enantiomer of pramipexole, for the potential treatment of amyotrophic lateral sclerosis.","volume":"13","author":"BC Cheah","year":"2010","journal-title":"IDrugs"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"230","DOI":"10.2174\/138161211795049732","article-title":"Antiapoptotic drugs: a therapautic strategy for the prevention of neurodegenerative diseases.","volume":"17","author":"FX Sureda","year":"2011","journal-title":"Curr Pharm Des"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1749-6632.2010.05865.x","article-title":"Neuroprotective properties of resveratrol and derivatives.","volume":"1215","author":"T Richard","year":"2011","journal-title":"Ann N Y Acad Sci"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1755-5949.2009.00105.x","article-title":"The antiapoptotic activity of melatonin in neurodegenerative diseases.","volume":"15","author":"X Wang","year":"2009","journal-title":"CNS Neurosci Ther"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s00439-007-0441-0","article-title":"Induction of full-length survival motor neuron by polyphenol botanical compounds.","volume":"122","author":"MS Sakla","year":"2008","journal-title":"Hum Genet"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/nrd3000","article-title":"Human stem cells and drug screening: opportunities and challenges.","volume":"9","author":"AD Ebert","year":"2010","journal-title":"Nat Rev Drug Discov"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0039113","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T14:47:22Z","timestamp":1540219642000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0039113"}},"subtitle":[],"editor":[{"given":"Thomas H.","family":"Gillingwater","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,6,19]]},"references-count":58,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2012,6,19]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0039113","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6,19]]}}}